ASCO GI Conference Coverage
Featured Articles
(TGen) Apr 25, 2017 - Adding cisplatin to the standard gemcitabine/nab-paclitaxel drug treatment provided a very high rate of tumor shrinkage for patients with advanced pancreatic cancer, according to the results of a pilot clinical trial conducted by the HonorHealth Research Institute and the Translational Genomics Research Institute...
Read Article
(Medscape Medical News) Jan 26, 2017 - Most cases of colorectal cancer are preceded by adenomas. Data show that chemoprevention with selective cyclooxygenase-2 (COX-2) inhibitors, particularly celecoxib (Celebrex, GD Searle), can reduce the incidence of these lesions.
Read Article
Latest Articles
January 25, 2017
January 25, 2017
January 25, 2017
January 23, 2017
January 23, 2017
January 23, 2017
January 23, 2017
January 23, 2017
View More
News Commentary
There is no ASCO GI Conference Coverage commentary.

OBR Green
There are no ASCO GI Conference Coverage OBR Green articles.
OBR Blog
By Emily Benesh, Ph.D., Analyst, Clinical & Scientific Assessment, Kantar Health and Stephanie Hawthorne, Ph.D.,... Read more
January 23, 2017
By Tari Awipi, Ph.D., Associate Consultant, Clinical & Scientific Assessment, Kantar Health and Jay Grisolano,... Read more
January 20, 2017